Vincent A. Miller

Concert Pharmaceuticals (United States) — United States

Medicine · Health Sciences

126h-index89.1kcitations1.2kworks0.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lung Cancer Treatments and Mutations(452), Cancer Genomics and Diagnostics(350), Lung Cancer Research Studies(119), Colorectal Cancer Treatments and Studies(113), HER2/EGFR in Cancer Research(107)

Publications1.2k total

Abstract P1-08-09: Real-World Outcomes Comparing 3-Monthly with Monthly Goserelin Implant in Premenopausal Women with Breast Cancer
Clinical Cancer Research·2025
A Concordance Study among 26 NGS Laboratories Participating in the NCI Molecular Analysis for Therapy Choice Clinical Trial
Clinical Cancer Research·2025Open Access
Real-world use of accelerated approval oncology drugs subsequently withdrawn in the United States.
Journal of Clinical Oncology·2025
Goserelin 3-month depot shows non-inferiority to the monthly formulation in U.S. patients with premenopausal breast cancer: a real-world evidence study
Breast Cancer Research and Treatment·2025Open Access
Real-world clinical outcomes among patients with non-squamous advanced non-small cell lung cancer (aNSCLC) treated with docetaxel-based regimens post initial standard of care (SOC) in the United States.
JCO Oncology Practice·2024
Expanding the landscape of oncogenic drivers and treatment options in acral and mucosal melanomas by targeted genomic profiling
International Journal of Cancer·2024· 4 citedOpen Access
Impact of Real-World Treatment Sequencing Patterns on Time to Next Treatment among Patients with Chronic Lymphocytic Leukemia in the United States
Blood·2023· 3 cited
Real-world treatment patterns and clinical outcomes post standard of care (SOC) among patients (pts) with metastatic non-small cell lung cancer (mNSCLC) with and without actionable genomic alterations (AGAs) in the United States (US).
JCO Oncology Practice·2023· 1 cited
Leveraging the Expertise of the CTSA Program to Increase the Impact and Efficiency of Clinical Trials
JAMA Network Open·2023· 15 citedOpen Access
Aumolertinib with chemotherapy or alone compared with osimertinib in patients with EGFR-mutant non–small-cell lung cancer (TREBLE).
Journal of Clinical Oncology·2023
Supplement Tables and Figures from Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness
2023Open Access
Data from Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness
2023Open Access
Data from Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness
2023Open Access
Supplement Tables and Figures from Phenotypic and Genomic Determinants of Immunotherapy Response Associated with Squamousness
2023Open Access
Data from <i>TP53</i> Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted Therapeutics
2023Open Access
Supplementary Figure 1 from <i>HER2</i> Amplification: A Potential Mechanism of Acquired Resistance to EGFR Inhibition in <i>EGFR</i>-Mutant Lung Cancers That Lack the Second-Site <i>EGFR</i><sup>T790M</sup> Mutation
2023Open Access
Supplementary Table 4 from Concordance of Genomic Alterations between Primary and Recurrent Breast Cancer
2023Open Access
Supplementary Data Figure 2 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
2023Open Access
Supplementary Figure 1 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
Supplementary Figure 2 from Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
2023Open Access
page 1 of 59Next →

Frequent Co-authors

Mark G. Kris(19), William Pao(17), Gregory J. Riely(14), Marc Ladanyi(14), Jeffrey S. Ross(13), Philip J. Stephens(10), Maureen F. Zakowski(9), Garrett M. Frampton(9), Roman Yelensky(9), Maria E. Arcila(8), Doron Lipson(7), Siraj M. Ali(6), Juliann Chmielecki(5), Geoff Otto(5), Roy S. Herbst(5), Valerie W. Rusch(4), Camelia S. Sima(4), Kai Wang(4), Maureen Cronin(4), Bruce E. Johnson(4)